Search results
Results from the WOW.Com Content Network
Pertuzumab is administered as an intravenous infusion in combination with trastuzumab and docetaxel as a first line treatment for HER2-positive metastatic breast cancer. [4] [3] It is also used in the same combination as a neoadjuvant (given to reduce the size of a tumor, prior to surgery or radiation) for HER2-positive early breast cancer; as of 2016 this use had not been shown to increase ...
The fixed-dose combination of pertuzumab, trastuzumab, and hyaluronidase was approved for medical use in the United States in June 2020. [5] [10]The FDA's approval was based on the results of a non-inferiority study in participants with HER2-positive early breast cancer, which demonstrated the fixed-dose combination of pertuzumab, trastuzumab, and hyaluronidase had comparable efficacy and ...
Assigning fixed-length 5-digit manufacturer codes, as the UCC has done until recently, means that each manufacturer can have up to 99,999 product codes.(9,999 for 3 digit GS1 prefix's) Many manufacturers do not have that many products, which means hundreds or even thousands of potential product codes are being wasted on manufacturers that only ...
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
In the United States, trastuzumab emtansine was approved specifically for treatment of HER2-positive metastatic breast cancer (mBC) in patients who have been treated previously with trastuzumab and a taxane (paclitaxel or docetaxel), and who have already been treated for mBC or developed tumor recurrence within six months of adjuvant therapy.
The Thomas Register of American Manufacturers, now Thomas, [1] is an online platform for supplier discovery and product sourcing in the US and Canada. It was once known as the "big green books" and "Thomas Registry", and was a multi-volume directory of industrial product information covering distributors, manufacturers and service companies [2] within thousands [3] of industrial categories ...
Code Country 001–019: UPC-A compatible - United States: 020–029: UPC-A compatible - Used to issue restricted circulation numbers within a geographic region [1] 030–039: UPC-A compatible - United States drugs (see United States National Drug Code) 040–049: UPC-A compatible - Used to issue restricted circulation numbers within a company ...